سعر انوكسيكام 20 مجم 20 قرص 2026

Tenoxicam 20 mg tablets, a non-steroidal anti-inflammatory drug of the oxicam class, made by Marcyrl, Egypt; 20 tablets (2 strips).

• Relief of pain and inflammation in osteoarthritis and rheumatoid arthritisPopulation: AdultsThai Food and Drug Administration (Thai FDA)
• Short-term management of acute musculoskeletal disorders including strains, sprains and other soft-tissue injuriesPopulation: AdultsThai Food and Drug Administration (Thai FDA)

• Very common: stomatitis. Common: dizziness, headache, gastrointestinal pain, dyspepsia, nausea, peptic ulcer. Uncommon: gastrointestinal haemorrhage, vertigo, palpitations, rash, raised hepatic enzymes, raised blood urea or creatinine, oedema. Rare: thrombotic events (e.g. myocardial infarction or stroke). Very rare: Stevens-Johnson syndrome, toxic epidermal necrolysis, pancreatitis.International label, equivalent formulation · Thai Food and Drug Administration (Thai FDA)

• Active or history of recurrent peptic ulcer or haemorrhage; history of gastrointestinal bleeding or perforation related to previous NSAID therapy; severe gastritis.International label, equivalent formulation · Thai Food and Drug Administration (Thai FDA)
• Hypersensitivity to tenoxicam or excipients, or asthma, rhinitis, angioedema or urticaria induced by aspirin or other NSAIDs.International label, equivalent formulation · Thai Food and Drug Administration (Thai FDA)
• Severe renal, hepatic or heart failure; third trimester of pregnancy.International label, equivalent formulation · Thai Food and Drug Administration (Thai FDA)

• Gastrointestinal bleeding, ulceration and perforation can occur at any time; higher risk in the elderly and with ulcer history; consider a protective agent (misoprostol or a proton pump inhibitor) in at-risk patients.International label, equivalent formulation · Thai Food and Drug Administration (Thai FDA)
• Cardiovascular and cerebrovascular thrombotic risk; caution in hypertension and heart failure (fluid retention and oedema).International label, equivalent formulation · Thai Food and Drug Administration (Thai FDA)
• Serious skin reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis; stop at the first appearance of rash or mucosal lesions.International label, equivalent formulation · Thai Food and Drug Administration (Thai FDA)

• Other NSAIDs including aspirin and COX-2 inhibitorsAvoid concomitant use: increased risk of adverse effects including gastrointestinal bleeding.Thai Food and Drug Administration (Thai FDA)
• Anticoagulants (e.g. warfarin)NSAIDs may enhance the effect of anticoagulants; close monitoring is required.Thai Food and Drug Administration (Thai FDA)
• Antiplatelet agents and SSRIsIncreased risk of gastrointestinal bleeding.Thai Food and Drug Administration (Thai FDA)

• Prostaglandin-synthesis inhibition may adversely affect pregnancy; avoid during the first and second trimesters unless clearly necessary, at the lowest dose for the shortest time.International label, equivalent formulation · Thai Food and Drug Administration (Thai FDA)
• NSAIDs should, if possible, be avoided when breastfeeding; after single doses a very small amount (mean less than 0.3% of the dose) of tenoxicam passes into breast milk, with no evidence of adverse reactions in breastfed infants.International label, equivalent formulation · Thai Food and Drug Administration (Thai FDA)

• Tenoxicam: Inhibits prostaglandin synthesis by inhibiting COX-1 and COX-2 to approximately the same extent (in vitro COX-2/COX-1 ratio 1.34), giving anti-inflammatory, analgesic and antipyretic effects.